Trials / Recruiting
RecruitingNCT06603597
HER2-positive Breast Cancer Registry
Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Priyanka Sharma · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Conditions
Timeline
- Start date
- 2024-09-27
- Primary completion
- 2044-10-01
- Completion
- 2044-10-01
- First posted
- 2024-09-19
- Last updated
- 2025-09-10
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06603597. Inclusion in this directory is not an endorsement.